Pavlicek, Valérie http://orcid.org/0000-0002-3758-4586
Mahfoud, Felix
Bubel, Katharina
Fries, Peter
Ewen, Sebastian
Böhm, Michael
Scheller, Bruno
Ukena, Christian
Funding for this research was provided by:
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Article History
Received: 1 November 2022
Accepted: 12 January 2023
First Online: 21 January 2023
Declarations
:
: FM has received scientific support and speaker honoraria from Bayer, Boehringer Ingelheim, Medtronic, and ReCor Medical. SE has received speaker honoraria from Medtronic, Recor, Bayer, Daiichi Sankyo, Novartis, AstraZeneca, Akcea Therapeutics and Pfizer. MB has received scientific support and speaker honoraria from Abbot, Amgen, Bayer, Boehringer Ingelheim, Medtronic, Novartis, Servier and ReCor Medical. CU has received scientific support and speaker Honoria from Bayer, Pfizer, Medtronic, and ReCor Medical. All other authors have no conflict of interest to report.
: The trial was approved by the Ethics Committee of the Saarland University. The trial was performed in accordance with the principles of the Declaration of Helsinki. All patients provided written informed consent prior to inclusion in the trial. The trial was registered at ExternalRef removed (NCT04128384).